These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19057554)

  • 1. Targeting RAS and PI3K in lung cancer.
    Downward J
    Nat Med; 2008 Dec; 14(12):1315-6. PubMed ID: 19057554
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways.
    Lackner MR
    Expert Rev Mol Diagn; 2010 Jan; 10(1):75-87. PubMed ID: 20014924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stopping ras in its tracks.
    Der CJ; Van Dyke T
    Cell; 2007 Jun; 129(5):855-7. PubMed ID: 17540164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3 kinases in cancer: from oncogene artifact to leading cancer target.
    Zhao JJ; Roberts TM
    Sci STKE; 2006 Dec; 2006(365):pe52. PubMed ID: 17164467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAS: target for cancer therapy.
    Saxena N; Lahiri SS; Hambarde S; Tripathi RP
    Cancer Invest; 2008 Nov; 26(9):948-55. PubMed ID: 18798058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
    Hoeflich KP; O'Brien C; Boyd Z; Cavet G; Guerrero S; Jung K; Januario T; Savage H; Punnoose E; Truong T; Zhou W; Berry L; Murray L; Amler L; Belvin M; Friedman LS; Lackner MR
    Clin Cancer Res; 2009 Jul; 15(14):4649-64. PubMed ID: 19567590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of Ras-PI3K interaction in the endosome using BiFC.
    Tsutsumi K; Fujioka Y; Tsuda M; Kawaguchi H; Ohba Y
    Cell Signal; 2009 Nov; 21(11):1672-9. PubMed ID: 19616621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical target promiscuity: lessons from ras molecular trials.
    Rengan R; Cengel KA; Hahn SM
    Cancer Metastasis Rev; 2008 Sep; 27(3):403-14. PubMed ID: 18461427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically targeting the PI3K family.
    Knight ZA; Shokat KM
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):245-9. PubMed ID: 17371250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PI3K and MEK: it is all about combinations and biomarkers.
    Rexer BN; Ghosh R; Arteaga CL
    Clin Cancer Res; 2009 Jul; 15(14):4518-20. PubMed ID: 19584146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of melanoma tumorigenesis.
    Singh M; Lin J; Hocker TL; Tsao H
    Br J Dermatol; 2008 Jan; 158(1):15-21. PubMed ID: 18047516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
    Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
    Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
    Cakir M; Grossman AB
    Expert Opin Ther Targets; 2009 Sep; 13(9):1121-34. PubMed ID: 19637976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PI-3 kinase for treating respiratory disease: good idea or bad idea?
    Thomas M; Owen C
    Curr Opin Pharmacol; 2008 Jun; 8(3):267-74. PubMed ID: 18394961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating cancer by blocking cell signals.
    Adjei AA; Hidalgo M
    J Clin Oncol; 2005 Aug; 23(23):5279-80. PubMed ID: 16091351
    [No Abstract]   [Full Text] [Related]  

  • 18. Using cells devoid of RAS proteins as tools for drug discovery.
    Urosevic J; Sum EY; Moneo V; Drosten M; Dhawahir A; Becerra M; Carnero A; Barbacid M
    Mol Carcinog; 2009 Nov; 48(11):1038-47. PubMed ID: 19526460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via ras/phosphatidylinositol 3-kinase/Akt pathway.
    Ram R; Uziel O; Eldan O; Fenig E; Beery E; Lichtenberg S; Nordenberg Y; Lahav M
    Clin Cancer Res; 2009 Feb; 15(3):914-23. PubMed ID: 19188162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations and response to epidermal growth factor receptor inhibitors.
    Laurent-Puig P; Lievre A; Blons H
    Clin Cancer Res; 2009 Feb; 15(4):1133-9. PubMed ID: 19228718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.